Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7774785 | 0.88 | KMT2A (0.40) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL7231881 | 0.88 | KMT2A (0.40) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL20032688 | 0.88 | MEN1 (0.40) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL14366810 | 0.84 | HSD11B1 (0.39) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL11772440 | 0.84 | ABCB11 (0.39) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL15869184 | 0.84 | TNK2 (0.40) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL4390019 | 0.84 | TNK2 (0.40) | HSD11B1KMT2AMEN1TNK2SLC6A3 | |
| SCHEMBL3500438 | 0.83 | TNK2 (0.44) | HSD11B1KMT2AMEN1TNK2DHFR | |
| SCHEMBL14049220 | 0.82 | ALDH1A1 (0.43) | KMT2AMEN1TNK2DHFR | |
| SCHEMBL825397 | 0.82 | ALDH1A1 (0.43) | KMT2AMEN1TNK2DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9618844-B2 | Reagent and composition of resist | TOYO GOSEI CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| US-9618844-B2 | Reagent and composition of resist | TOYO GOSEI CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| US-20160195808-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO LTD (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160195808-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO LTD (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160159953-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO LTD (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160159953-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | TOYO GOSEI CO LTD (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | OSAKA UNIVERSITY (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | OSAKA UNIVERSITY (JP) | 2016-03-10 | — | — | US | disclosed |
| US-5053507-A | Liquid crystal dopants | ARAKAWA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-10-01 | — | — | US | disclosed |
| US-3940407-A | β-Adrenergic blocking agents in the 1,2,3-thiadiazole series | SYNTEX (U.S.A.) INC. (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | ALAD, POLRMT, POLL | HSD11B1 3383/4885KMT2A 1839/4885MEN1 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.